Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
7.03 HKD | +2.03% | +3.84% | -3.17% |
10:04am | Nomura Adjusts CSPC Pharmaceutical’s Price Target to HK$10.07 From HK$9.41, Keeps at Buy | MT |
May. 27 | CSPC Pharmaceutical Group's Q1 Profit Rises 12% | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-3.17% | 10.45B | |
+38.17% | 727B | |
-7.55% | 354B | |
+15.89% | 328B | |
-0.23% | 277B | |
+13.47% | 243B | |
+7.35% | 205B | |
-6.42% | 203B | |
+3.99% | 164B | |
-1.93% | 164B |
- Stock Market
- Equities
- 1093 Stock
- News CSPC Pharmaceutical Group Ltd.
- U.S. Regulator Allows CSPC Pharmaceutical to Conduct Clinical Trials for Anti-Tumor Drug